BioSpace News Archive

Biogen Inc. (Nasdaq: BIIB) today announced that they have entered into an agreement whereby Samsung Biologics will acquire Biogen’s equity stake in the Samsung Bioepis joint venture for an aggregate consideration of up to USD $2.3 billion.

Acer Therapeutics Inc. and its collaboration partner, RELIEF THERAPEUTICS Holding SA, announced the acceptance of four ACER-001 abstracts for poster presentations at the upcoming Society for Inherited Metabolic Disorders Annual Meeting on April 10-13, 2022 in Orlando, Florida, and the Genetic Metabolic Dieticians International Conference on May 4-7, 2022, in Las Vegas, Nevada.

AcelRx Pharmaceuticals, Inc. today announced the publication of an article reviewing the use of sufentanil sublingual tablet (SST; DSUVIA ® ) for pain medicine procedures by lead author Dr. Sarang Koushik in Current Pain and Headache Reports.

Perimeter Medical Imaging AI, Inc. is pleased to announce the closing of its previously announced private placement of units (each, a “Unit”) for gross proceeds of C$48.7 million to the Company (the “Private Placement”).

Blaine Labs Company is voluntarily recalling one lot of RevitaDerm Wound Care to the consumer level because a bottle of the 1.0 ounce RevitaDerm Wound Care Gel has been found to be contaminated with Bacillus cereus.

Movano Inc., a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced it has been awarded three new U.S. patents, increasing its total number of issued U.S. patents to six.

The industry analysis report is considered a valuable source of information about the global Dermatology Devices industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

The global Horseradish Peroxidase (HRP) market research report is a comprehensive report published by Reports and Data that evaluates the market size and share, growth opportunities, risks and limitations, and market growth curve.

The industry analysis report is considered a valuable source of information about the global Retinal Implants industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

First potential FEVR therapy to obtain U.S. Food and Drug Administration Orphan Drug Designation.